VYSIONEER
Vysioneer is an oncology AI company that enables pharma and clinicians to find the right treatment for tumors. The company unlocks drug efficacy with lesion-level precision to de-risk and accelerate clinical trials.
VYSIONEER
Industry:
Artificial Intelligence (AI) Health Care Health Diagnostics Oncology Software
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.vysioneer.com
Total Employee:
11+
Status:
Active
Contact:
609-865-8659
Email Addresses:
[email protected]
Total Funding:
750 K USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Google Font API GStatic Google Static Content Apple Mobile Web App Capable Apple Mobile Web App Status Bar Style OpenResty Next.js Fastly Hosted Ruby On Rails
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
bridge7
Bridge7 develops AI-powered consultation software that ensures patients receive care from cancer treatment centers.
Infervision
Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
Navina
Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits for better diagnoses and care.
Oncora Medical
Oncora Medical is a digital health company integrating big data and machine learning into radiation oncology.
Pera Labs
Pera Labs develops digiceuticals and AI-powered solutions for fertility.
Syllable
Syllable uses AI to transform the way healthcare systems initiate and cultivate relationships with patients.
Current Employees Featured
Founder
Official Site Inspections
http://www.vysioneer.com Semrush global rank: 9.46 M Semrush visits lastest month: 375
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Vysioneer"
VYSIONEER
Jan 17, 2024 Vysioneer. Unlocking lesion-level insights to make oncology trials smaller and faster. Problem. Tumor heterogeneity. 60% of cancer patients develop a mixture of shrinking, โฆSee details»
Vysioneer - Crunchbase Company Profile & Funding
Organization. Vysioneer . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Vysioneer is an oncology AI company that โฆSee details»
Vysioneer - LinkedIn
Vysioneer is an oncology AI company. We aim to improve the clarity about tumor heterogeneity in cancer treatment with lesion-level data. Leveraging our FDA-cleared AI platform, we help โฆSee details»
Vysioneer 2025 Company Profile: Valuation, Funding & Investors
Vysioneer General Information Description. Developer of a tumor auto-contouring platform designed to provide precision radiosurgery. The company's platform provides a system for โฆSee details»
Vysioneer Company Profile | Management and Employees List
Vysioneer Profile and History Vysioneer is a leading AI solution provider, aiming to pioneer the transformation in Cancer Care using Artificial Intelligence. The company leverages its โฆSee details»
Vysioneer - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 23, 2025 Vysioneer. has raised a total funding of $2.78M over 3 rounds. Its first funding round was on Sep 10, 2019. List of recent funding rounds of Vysioneer. Date of funding. โฆSee details»
Vysioneer - Products, Competitors, Financials, Employees, โฆ
Vysioneer focuses on leveraging artificial intelligence to improve oncology treatment efficacy within the pharma and biotech sectors. Its main offerings include an AI-powered platform that โฆSee details»
Vysioneer - Funding, Financials, Valuation & Investors - Crunchbase
Vysioneer is an oncology AI company that enables pharma and clinicians to find the right treatment for tumors. New. ... Experience the new Crunchbase, powered by AI . Experience โฆSee details»
Vysioneer, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Vysioneer has also tested the device through an 18-month clinical integration at National Taiwan University Hospital (NTUH). According to the company, clinical findings showed that clinicians โฆSee details»
About - Vysioneer
Vysioneer is an oncology AI company with a mission to use machine learning to bring therapies to cancer patients in need sooner. Our journey began with the belief that every tumor matters in โฆSee details»
Vysioneer - Overview, News & Similar companies | ZoomInfo.com
Apr 4, 2021 Vysioneer is a leading AI solution provider, aiming to pioneer the transformation in Cancer Care using Artificial Intelligence. The company leverag es its proprietary deep learning โฆSee details»
Vysioneer, Mary Bird Perkins Cancer Center Endeavor To Make โฆ
Nov 10, 2020 Vysioneer is headquartered in Boston and has an office in Taipei, Taiwan. Find out more at www.vysioneer.com, and follow the company on Linkedin. About Mary Bird โฆSee details»
Vysioneer - Contacts, Employees, Board Members, Advisors
Vysioneer is an oncology AI company that enables pharma and clinicians to find the right treatment for tumors. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. โฆSee details»
Vysioneer Receives FDA Clearance on First-Ever Tumor Auto โฆ
Apr 5, 2021 VBrain has been integrated through Vysioneer's partnership with Mary Bird Perkins Cancer Center, a cancer care organization headquartered in Baton Rouge, โฆSee details»
VYSIONEER
Vysioneer. Unlocking lesion-level insights to make oncology trials smaller and faster. Problem. Tumor heterogeneity. 60% of cancer patients develop a mixture of shrinking, stable, and โฆSee details»
Vysioneer Improves Precision Radiation Therapy with AI - NVIDIA โฆ
Dec 9, 2019 Vysioneer is working towards FDA clearance for VBrain and plans to launch contouring AI models for medical images of other parts of the body. The company also plans โฆSee details»
As a second set of eyes and hands for clinicians, VBrain ... - Vysioneer
Apr 4, 2021 VBrain has been integrated through Vysioneerโs partnership with Mary Bird Perkins Cancer Center, a cancer care organization headquartered in Baton Rouge, Louisiana. โฆSee details»
Vysioneer Announces Data Sharing Agreement with Pfizer to โฆ
Feb 21, 2023 Vysioneer is a pioneer in applied artificial intelligence in oncology. With the world's largest database of lesion-level clinical data and a regulatory-grade AI platform, Vysioneer โฆSee details»
Vysioneer
Sign In Reset Password. Sign in with GoogleSee details»
Pharma / Biotech - Vysioneer
Sno/asco 2023 | real-world data| in collaboration with stanford medicine. sdps-09 mixed response of brain metastases treated with osimertinib predicts inferior survival outcomes: an artificial โฆSee details»